Therefore, a recent study conducted on streptozotocin-induced diabetic nephropathy in mice showed that EGCG 100 mg/kg might provide an effective protection against diabetic nephropathy by osteopontin suppression suggesting that this flavonoid may provide supportive aid for management of diabetes mellitus patients with nephropathy [97]. Here, SPP1 is linked to diabetes mellitus.